IMPROVING MENTAL HEALTH OUTCOMES IN EPILEPSY: THE EFFECT OF COUNSELLING ON DRUG-INDUCED COGNITIVE AND BEHAVIORAL CHANGES
DOI:
https://doi.org/10.22159/ajpcr.2026v19i4.58085Keywords:
Epilepsy,, Antiepileptic drugs,, Patient counseling,, Cognitive impairment, Behavioral adverse effects.Abstract
Objectives: The objective of the study was to assess the impact of patient counseling on cognitive impairment and behavioral adverse effects associated with antiepileptic drug (AED) therapy among emerging adults with epilepsy.
Methods: This prospective pre-post interventional study was conducted in the Department of Neurology at a tertiary care hospital in Kerala from May 2024 to October 2024. A total of 47 patients with epilepsy aged 18–29 years who were receiving AED therapy were included. The impact of patient counseling on cognitive impairment and behavioral adverse effects of AEDs was assessed using baseline and follow-up evaluations.
Results: Among the emerging adults with epilepsy, the mean age was approximately 20 years, and males constituted 68% of the study population. Levetiracetam was the most frequently prescribed AED, accounting for 47% of prescriptions. The mean cognitive impairment score decreased from 18.21±0.954 at baseline to 15.32±0.471 at the final follow-up. Similarly, the mean behavioral adverse-effect score decreased from 18.15±1.000 at baseline to 15.21±0.657 at follow-up. These findings indicate improvement in cognitive and behavioral outcomes following patient counseling.
Conclusion: Patient counseling appears to improve cognitive and behavioral outcomes in emerging adults receiving AED therapy. Strengthening communication between healthcare providers and patients may enhance treatment understanding, reduce adverse effects, and improve quality of life. Further studies with larger samples and comparative designs are needed to confirm these findings.
Downloads
References
1. Noe K. Counseling and management of the risks of living with epilepsy. Continuum (Minneap Minn). 2019 Apr 1;25(2):477-91. doi: 10.1212/ con.0000000000000708, PMID 30921019
2. Sravanthi K, SaiSpoorthy BV, NagulShareef SK, BhavyaSai S, Suresh Kumar JN. Cognitive and behavioral effects of anti-epileptic drugs in epilepsy patients using MMSE scales and DSM-V criteria a comparative study. World J Pharm Res. 2020 Oct 25;9(14):842-59.
3. Koshy S. Role of pharmacists in the management of patients with epilepsy. Int J Pharm Pract. 2011;20(1):65-8. doi: 10.1111/j.2042- 7174.2011.00156.x, PMID 22236182
4. Ortinski P, Meador KJ. Cognitive side effects of antiepileptic drugs. Epilepsy Behav. 2004;5 Suppl 1:S60-5. doi: 10.1016/j. yebeh.2003.11.008, PMID 14725848
5. Santhosh NS, Sinha S, Satishchandra PS. Epilepsy: Indian perspective. Ann Indian Acad Neurol. 2014 Mar;17 Suppl 1:S3- 11. doi: 10.4103/0972-2327.128643, PMID 24791085, PMCID PMC4001222
6. Radhakrishnan K, Pandian JD, Santhoshkumar T, Thomas SV, Deetha TD, Sarma PS. Prevalence, knowledge, attitude, and practice of epilepsy in Kerala, South India. Epilepsia. 2000 Aug;41(8):1027-35. doi: 10.1111/j.1528-1157.2000.tb00289.x, PMID 10961631
7. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia. 2003;44 Suppl 4:21-9. doi: 10.1046/j.1528- 1157.44.s4.3.x
8. Piazzini A, Canevini MP, Turner K, Chifari R, Canger R. Elderly people and epilepsy: Cognitive function. Epilepsia. 2006;47 Suppl 5:82-4. doi: 10.1111/j.1528-1167.2006.00884.x, PMID 17239113
9. Elrashidy GG. Introduction to Pharmacy Practice (PP. 3202). Patient Counselling for Epilepsy [preprint]; 2020 Jul. doi: 10.13140/ rg.2.2.13447.62883/1
10. Epilepsy Foundation. What Is Epilepsy? Understanding Seizures: Risk Factors. Landover, MD: Epilepsy Foundation; 2025 Available from: https://www.epilepsy.com/what-is-epilepsy/understanding-seizures/ risk-factors [Last accessed on 2025 Aug 18].
11. Namratha MV, Anuradha HV, Mahendra JV. Neuropsychological side effects of anti-epileptic drugs in epilepsy patients: A cross sectional study. Int J Basic Clin Pharmacol. 2023;12(6):788-93. doi: 10.18203/2319-2003.ijbcp20232845
12. Pal SK, Sharma K, Prabhakar S, Pathak A. Neuroepidemiology of epilepsy in Northwest India. Ann Neurosci. 2010;17(4):160-6. doi: 10.5214/ans.0972.7531.1017404, PMCID PMC4117013. PMID 25205899
13. Martin RC, Griffith HR, Faught E, Gilliam F, Mackey M, Vogtle L. Cognitive functioning in community dwelling older adults with chronic partial epilepsy. Epilepsia. 2005 Feb;46(2):298-303. doi: 10.1111/j.0013-9580.2005.02104.x, PMID 15679511
14. Lee JW, Alam J, Llewellyn N, Hurwitz S, Bubrick EB, Sarkis RA. Open label trial of add on lacosamide versus high dose levetiracetam monotherapy in patients with breakthrough seizures. Clin Neurophysiol. 2016 May-Jun;39(3):128-31. doi: 10.1097/wnf.0000000000000144, PMID 26992155
15. Hophing L, Kyriakopoulos P, Bui E. Sex and gender differences in epilepsy. Int Rev Neurobiol. 2022;164:235-76. doi: 10.1016/ bs.irn.2022.06.012, PMID 36038205
16. De Souza JL, Faiola AS, Miziara CS, De Manreza ML. The perceived social stigma of people with epilepsy with regard to the question of employability. Neurol Res Int. 2018;2018:4140508. doi: 10.1155/2018/4140508, PMID 29862075
17. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: Contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc. 1996;71(6):576-86. doi: 10.4065/71.6.576, PMID 8642887
18. Fisher RS, Van Emde Boas W, Blume W, Elger C, Genton P, Lee P. Epileptic seizures and epilepsy: Definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia. 2005;46(4):470-2. doi: 10.1111/j.0013-9580.2005.66104.x, PMID 15816939
19. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000 Feb 3;342(5):314-9. doi: 10.1056/nejm200002033420503, PMID 10660394
20. Salinsky MC, Oken BS, Binder LM. Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy. Epilepsia. 1996;37(2):181-7. doi: 10.1111/j.1528-1157.1996.tb00010.x, PMID 8635429
21. Surendranath A, Singhal S, Khanna R, Rath S, Mihaylova T. The impact of age on outcomes in seizure hospitalizations-analysis of a national sample. Neurol Int. 2025 Sep;17(3):39. doi: 10.3390/ neurolint17030039, PMID 40137460
22. Aldenkamp AP, Arends J. The effects of antiepileptic drugs on cognition: What can we learn from neuropsychology? Epilepsia. 2004;45 Suppl 1:19-23.
23. Scott AJ, Sharpe L, Hunt C, Gandy M. Anxiety and depressive disorders in people with epilepsy: A meta-analysis. Epilepsia. 2017;58(6):973-82. doi: 10.1111/epi.13769, PMID 28470748
24. Miller LA, Galioto R, Tremont G, Davis J, Bryant K, Roth J. Cognitive impairment in older adults with epilepsy: Characterization and risk factor analysis. Epilepsy Behav. 2016 Mar;56:113-7. doi: 10.1016/j.yebeh.2016.01.011, PMID 26859320
Published
How to Cite
Issue
Section
Copyright (c) 2026 VINEETHA S, HEMALATHA SELVARAJ, DAVIS MANUEL A
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.